In humans, data on dopamine and DAT availability, measured with different brainimaging modalities or in postmortem brains, are divergent [25, 26, 28, 30, 131, 132], and so are the results of GLP1RAinduced DAT availability [69]
This also highlights another obstacle: a lack of understanding about OSA even within parts of the medical community (1)
PHARMACOKINETICS In a relative bioavailability study in 15 healthy adult male volunteers, levocarnitine tablets were found to be bio-equivalent to levocarnitine oral solution
Then, correcting deficiencies helps restore cellular function and improve mitochondrial energy production, support lean muscle mass, and create a more resilient metabolism that can better maintain weight and appetite regulation after coming off a GLP-1
This was also seen to be associated with alterations in gut-derived metabolites 16